Interestingly, as previously reported in all-trans retinoic acid-resistant colon cancer cells, SphK2 overexpression resulted in the downregulation of endogenous RXRα (39), but not of LXRα/β (supplemental Fig. S8A–C). Here, SPHK2 is linked to malignant colon neoplasm.